Press Releases - 2022-05-31

Date	Title	Company
31-May-2022	Vita 34 sees first signs of stabilization in core business after war-related weaker first quarter	Vita 34 AG
31-May-2022	Median Technologies launches Imaging Lab, spearheading the integration of iBiopsy® Artificial Intelligence technologies into iCRO imaging services for oncology trials	Median Technologies
31-May-2022	Clasado Biosciences has poster accepted at ISAPP 2022	Clasado Biosciences
31-May-2022	Transine Therapeutics Announces Final Closing of its Seed Round at £13.7m to Accelerate its Platform and Portfolio Development	Transine Therapeutics
31-May-2022	Priothera Receives Fast Track Designation for mocravimod in Combination with Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for Post Remission Therapy of Acute Myeloid Leukemia (AML) Patients	Priothera
31-May-2022	ViiV Healthcare announces marketing approval by Japan’s Ministry of Health, Labour and Welfare for Vocabria (cabotegravir) used in combination with Rekambys (rilpivirine), the first and only complete long-acting treatment for HIV	ViiV Healthcare
31-May-2022	FDA Approves Label Extension for Evrysdi® for Infants with Spinal Muscular Atrophy Under 2 Months Old	PTC Therapeutics
31-May-2022	Update on Cialis® Rx-to-OTC Switch Actual Use Trial	Sanofi
31-May-2022	argenx Announces the UK MHRA has Granted Early Access to Efgartigimod for Generalized Myasthenia Gravis	argenx
31-May-2022	US FDA accepts New Drug Application filed by Avillion for AstraZeneca’s PT027 for the as-needed treatment or prevention of symptoms in asthma patients	AstraZeneca
31-May-2022	Bavarian Nordic Enters Additional Vaccine Contracts with Governments in Response to Monkeypox Outbreak	Bavarian Nordic
31-May-2022	Minoryx raises EUR 51 million to support Marketing Authorization Application and launch preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy	Minoryx Therapeutics
31-May-2022	First subject dosed in Lipigon’s phase I clinical study with antisense oligonucleotide candidate derived from Secarna Pharmaceutical’s LNAplus™ technology platform	Secarna Pharmaceuticals GmbH & Co. KG
31-May-2022	Sports Medicine Market Insights, Deep Analysis of Key Vendor in the Industry 2021-2031	MARKITWIRED
31-May-2022	Knee Reconstruction Market Industry Research, Segmentation, Key Players Analysis and Forecast to 2031	MARKITWIRED
31-May-2022	Herpes Labialis Treatment Market is expected to register a CAGR of nearly 4.7% over the forecast period 2022-2028	MARKITWIRED
31-May-2022	Anti-Osteoporosis Therapy and Fracture Healing Market to record a CAGR of 3% through 2030	MARKITWIRED
31-May-2022	Cervical Pillows Market is expected to enjoy a market valuation of US$ 1.2 Billion in 2022	MARKITWIRED
31-May-2022	FDA accepts Dupixent® (dupilumab) for priority review in adults with prurigo nodularis	Sanofi
31-May-2022	Bone Therapeutics signs definitive subscription agreement for a maximum of EUR 5M convertible bonds facility with ABO	Bone Therapeutics